These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 35700634)

  • 1. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
    Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
    Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
    Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
    Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
    Crotti L; Neves R; Dagradi F; Musu G; Giannetti F; Bos JM; Barbieri M; Cerea P; Giovenzana FLF; Torchio M; Mura M; Gnecchi M; Conte G; Auricchio A; Sala L; Odening KE; Ackerman MJ; Schwartz PJ
    Circulation; 2024 Aug; 150(7):531-543. PubMed ID: 38939955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a human-induced pluripotent stem cell line, KSCBi014-A, from a long QT syndrome type 2 patient harboring a KCNH2 mutation.
    Lee Y; Koo SK; Kim JH
    Stem Cell Res; 2021 Dec; 57():102570. PubMed ID: 34678663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes.
    Park NK; Park SJ; Park YG; Moon SH; Woo J; Kim HJ; Kim SJ; Choi SW
    Hum Mol Genet; 2024 Jan; 33(2):110-121. PubMed ID: 37769355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2
    Ono M; Burgess DE; Schroder EA; Elayi CS; Anderson CL; January CT; Sun B; Immadisetty K; Kekenes-Huskey PM; Delisle BP
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32759882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
    Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of a human induced pluripotent stem cell line from a long QT syndrome patient harboring a heterozygous mutation of c.1537C > T in SCN5A gene.
    Chen J; Song Y; Gu J; Chen L
    Stem Cell Res; 2021 Dec; 57():102576. PubMed ID: 34678660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a human induced pluripotent stem cell line ZZUNEUi030-A from a female patient carrying a heterozygous CALM2 (c.395 A > T) mutation.
    Hua C; Sun W; Zhang C; Tian X; Qin X; Dong J; Li X
    Stem Cell Res; 2024 Aug; 81():103515. PubMed ID: 39137556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human iPSC line CIPi003-A from a patient with focal epilepsy harboring a heterozygous mutation in DEPDC5 gene.
    Shen M; Fan S; Wu F; Cheng P; Gao Y; Zheng P; Feng S; Ji X; Chen Q; Zhang X
    Stem Cell Res; 2023 Oct; 72():103195. PubMed ID: 37722146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of FDHSi003-A, a human induced pluripotent stem cell (hiPSC) line with a mutation of RNF216 c.1948G > T.
    Xu W; Chen K; Guo M; Dong Q; Cui M
    Stem Cell Res; 2024 Apr; 76():103347. PubMed ID: 38377650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous TTN (c. 79,684C>T) mutant human induced pluripotent stem cell line (ZZUNEUi023-A) generated from a Kazakh patient with dilated cardiomyopathy.
    Li X; Wei W; Li X; Qi L; Lu S; Wei H; Liu Y; Dong J; Zhang C; Lin T
    Stem Cell Res; 2021 Dec; 57():102614. PubMed ID: 34883393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An induced pluripotent stem cell line (SDQLCHi062-A) from a patient carrying a mutation in the PAX2 gene.
    Yang X; Zhang H; Gao M; Lv Y; Song W; Duan C; Liu Y
    Stem Cell Res; 2023 Dec; 73():103260. PubMed ID: 38029557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line from patient with atrial fibrillation with KCNQ1 p.Ser209Pro mutation.
    Cen Y; Zhou T; Chen S; Deng Z; Wang J; Ma N; Zhang S
    Stem Cell Res; 2024 Apr; 76():103336. PubMed ID: 38341987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene.
    Li X; Lu Y; Wang J; Liu M; Wang M; Hu L; Du W; Wang L; Jiang Z; Gu X; Ding Z; Feng D; Li L; Dong J; Zhao X
    Stem Cell Res; 2020 Jun; 47():101882. PubMed ID: 32592953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individual.
    Fu W; Wang M; Liu Y; Liu M; Wang L; Hu L; Zhao X; Ding Z; Li X; Dong J
    Stem Cell Res; 2020 Dec; 50():102139. PubMed ID: 33383407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
    Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
    Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
    Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.